EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
07.01.25
/
50%
€8.89
Target price
07.01.26
€31.74
Performance (%)
63.26%
End price
08.01.26
€14.52
Summary
This prediction ended on 08.01.26 with a price of €14.52. With a performance of 63.26% the BUY prediction by Citigroup_Inc_ was a big success. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -15.872% | -15.872% | 56.223% |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $33.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten